Abbott ABT Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.8B+4.1% | $8.52B+11.9% | $7.51B-0.6% | $6.95B-0.5% | $6.53B+3.9% | ||
| $8.21B+12.1% | $7.93B+14.5% | $8.14B+15.4% | $7.97B+16.3% | $7.33B+10.9% | ||
| $6.99B+5.3% | $6.49B+4.7% | $6.71B-1.5% | $6.95B+2.1% | $6.64B-2.8% | ||
| $25.51B+10.2% | $26B+9.9% | $24.84B+4.4% | $24.47B+5.8% | $23.15B+3.5% | ||
| $12.38B+13.2% | $11.82B+10.9% | $11.5B+8.3% | $11.4B+11.4% | $10.93B+8.2% | ||
| $35.22B+50.8% | $24.04B+4.0% | $23.97B+1.3% | $23.95B+2.8% | $23.36B-0.1% | ||
| $110.43B+35.6% | $86.71B+6.5% | $84.18B+13.2% | $84B+15.0% | $81.45B+12.4% | ||
| $4.68B+11.0% | $4.24B+1.1% | $4.12B+2.2% | $4.31B+4.4% | $4.21B+0.9% | ||
| $4.41B+771% | $3.03B+102% | $1.35B-37.6% | $507M-68.6% | $506M-74.8% | ||
| $18.38B+41.3% | $16.5B+16.5% | $14.58B-2.1% | $13.44B-2.3% | $13B-7.3% | ||
| $29.64B+133% | $9.9B-21.6% | $11.6B-9.6% | $12.93B-1.6% | $12.74B+1.3% | ||
| —— | —— | —— | —— | —— | ||
| $49.96B+4.7% | $49.78B+5.3% | $49.1B+25.7% | $48.47B+26.4% | $47.72B+25.5% | ||
| $52.06B+6.7% | $52.13B+9.4% | $50.95B+28.0% | $50.57B+28.6% | $48.81B+25.8% | ||
| $110.43B+35.6% | $86.71B+6.5% | $84.18B+13.2% | $84B+15.0% | $81.45B+12.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Abbott's total assets?
- Abbott (ABT) holds $110.43B in total assets, up 35.6% year over year.
- How much debt does Abbott have?
- Abbott carries $34.0B in total debt against $52.1B of shareholders' equity, a debt-to-equity ratio of 0.65.
- How much cash does Abbott have?
- Abbott holds $6.8B in cash and equivalents.
- Can Abbott cover its short-term obligations?
- Its current ratio is 1.39 — current assets exceed current liabilities.
- Where does Abbott's balance sheet data come from?
- Every line is extracted from Abbott's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
